Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
OPK
#2158
Opko Health Inc.
1.2
0
+1.69%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+1.69%
Monthly Change
-6.98%
6 month change
-15.49%
Year Change
-28.99%
Previous Close
1.1
8
Open
1.2
0
Bid
Ask
Low
1.2
0
High
1.2
0
Volume
105
Markets
US Stock Market
Healthcare
OPK
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2020
2021
2022
2023
2024
2025
Total assets
2.47 B
2.4 B
2.17 B
2.01 B
2.2 B
1.93 B
Total liabilities
801.51 M
714.59 M
605.61 M
622.48 M
834.76 M
663.99 M
Total equity
1.67 B
1.69 B
1.56 B
1.39 B
1.37 B
1.27 B
Total liabilities & shareholders' equities
2.47 B
2.4 B
2.17 B
2.01 B
2.2 B
1.93 B
Total debt
—
—
—
—
—
—
Net debt
—
—
—
—
—
—
Opko Health Inc
OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".
News
OPK Q4 Earnings & Revenues Beat Estimates, Gross Margin Contracts
OPKO Health, Inc. (OPK) Q4 2025 Earnings Call Transcript
Opko Health earnings beat by $0.03, revenue topped estimates
Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026?
Opko Health stock rating reiterated at Buy by H.C. Wainwright
OPKO Health: Deeply Mispriced Ahead Of Major Catalysts (NASDAQ:OPK)
OPKO Health, Inc. (OPK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
OrthoPediatrics (KIDS) Moves 9.8% Higher: Will This Strength Last?
OPKO Health Bets on RAYALDEE and Pipeline Progress for 2026 Growth
Here's Why You Should Retain OPKO Health Stock in Your Portfolio Now
CollPlant Biotechnologies schedules annual and extraordinary meeting for December 31
JPMorgan initiates Opko Health stock with Neutral rating